http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005112952-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6f41f5f75dbad43c5ec2e21a070b910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c2556556e58c15c39558b42c53119f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_751e8522868a43324f760cd4c8d9010f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b22ad483d9c4118515f5b78624fd3ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_678317f7d7e5cb57e28d1a9fa71aa72a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D225-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
filingDate 2005-05-19^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86169c70dc6acfb0f23289d98d8f6a32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a9b20513bfc0b08afb8f0fa26518b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5990320b41d46e8aeb521c1d576f9e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63b679bfb57c2679b13180d1835eb417
publicationDate 2007-09-27^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005112952-A3
titleOfInvention Geldanamycin compounds and method of use
abstract Geldanamycin compounds having a structure according to formula (I) where Q1, L, L1, R5, R6 and R11 are as defined herein, are useful for treating a disease or disorder ameliorated by inhibiting the function of extracellular heat shock protein-90.
priorityDate 2004-05-20^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6670348-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73554183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452192324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288382

Showing number of triples: 1 to 36 of 36.